KYORIN Pharmaceutical Co., Ltd. (KYRNF)
10.31
0.00 (0.00%)
USD |
OTCM |
May 14, 16:00
KYORIN Pharmaceutical EPS Diluted (Quarterly) : -0.0744 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -0.0496 |
| Daiichi Sankyo Co., Ltd. | 0.1472 |
| Eisai Co., Ltd. | 0.0988 |
| Chugai Pharmaceutical Co., Ltd. | 0.2235 |
| Santen Pharmaceutical Co., Ltd. | 0.3043 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.277M |
| Revenue (Quarterly) | 215.43M |
| Total Expenses (Quarterly) | 219.71M |
| Enterprise Value | 647.04M |
| Gross Profit Margin (Quarterly) | 35.76% |
| Profit Margin (Quarterly) | -1.99% |
| Earnings Yield | 3.91% |
| Operating Earnings Yield | 4.04% |